baber/WOPTO huggingface dataset:
Patent MX-2020011643-A (MX)
Title: Transmitter and parity permutation method thereof.
Inventor: KIM KYUNG-JOONG
IPC: H03M13/11
Filed: 2017-08-30
Abstract: A transmitter is provided. The transmitter includes: a Low Density Parity Check (LDPC) encoder configured to encode input bits to generate parity bits; a parity permutator configured to group-wise interleave a plurality of bit groups including the parity bits; and a puncturer configured to select some of the parity bits in the group-wise interleaved bit groups and puncture the selected parity bits, wherein the parity permutator group-wise interleaves the bit groups such that some of the bit groups at predetermined positions in the bit groups before the group-wise interleaving are positioned serially after the group-wise interleaving and a remainder of the bit groups before the group-wise interleaving are positioned without an order after the group-wise interleaving so that the puncturer selects parity bits included in the some of the bit groups sequentially and selects parity bits included in the remainder of the bit groups without an order.
Patent MX-2020012993-A (MX)
Title: Peptide having anti-diabetic and anti-obesity effects, and use thereof.
Inventor: CHUNG YONG JI
IPC: A61P3/04
Filed: 2015-05-12
Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPARÎ³, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-Î±1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
Patent MX-2020013488-A (MX)
Title: Emergency function and configuration for autonomous civil vehicles.
Inventor: RODRÍGUEZ VEGA CARLOS MANUEL
IPC: B60Q7/02
Filed: 2020-12-10
Abstract: The present invention relates to an emergency function and configuration system for autonomous civil vehicles so that, in the event of a medical emergency event, an ordinary person can call the assistance services, allowing using any private vehicle as an ambulance to reach the nearest hospital.
Patent MX-2020013886-A (MX)
Title: Glazing comprising a stack of thin layers acting on solar radiation and a barrier layer.
Inventor: BRALEY CAROLE
IPC: C03C17/23
Filed: 2019-06-27
Abstract: The invention relates to a transparent substrate (S), in particular made of glass, comprising a stack (10) of thin layers acting on solar radiation, said stack including at least one functional layer (11) which is associated with at least one barrier underlayer (12), characterized in that said barrier underlayer is a silicon dioxide layer with a thickness between 15 and 25 nm.
Patent MX-2021000902-A (MX)
Title: Cellulite treatment system and methods.
Inventor: BRIGHT EARL
IPC: A61B17/32
Filed: 2019-07-22
Abstract: Systems and methods for treating cellulite including an apparatus that applies or a method involving separating septa to eliminate or reduce the appearance of cellulite. In one approach, an interventional tool is placed between tissue layers to engage and treat septa connecting tissue layers between which fat deposits are contained.
Patent MX-2021003511-A (MX)
Title: Process for forming a laminate.
Inventor: BARRETTO ABRAHAM
IPC: B32B27/08
Filed: 2019-09-20
Abstract: The present disclosure provides a process. The process includes (A) providing at least 6 film layers, each film layer being a pearlized biaxially oriented polypropylene; (B) applying a solvent-less adhesive at a coat weight of 2.0 g/m2 to 3.5 g/m2 between each film layer; and (C) forming a laminate, the laminate having a thickness of at least 300 µm. The solvent-less adhesive contains (i) a polyol component including at least one polyol selected from a polyester polyol, a polyether polyol, and combinations thereof; and (ii) an isocyanate component including an isocyanate prepolymer that is the reaction product of at least one isocyanate monomer and at least one polyol selected from a polyester polyol, a polyether polyol, and combinations thereof. The present disclosure also provides a laminate formed by said process.
Patent MX-2021006135-A (MX)
Title: Thermoplastic resin composition and molded article.
Inventor: MUTO FUMIHIRO
IPC: C08L37/00
Filed: 2019-11-25
Abstract: This thermoplastic resin composition is characterized by containing not less than 20 parts by mass but less than 50 parts by mass of a polyalkylene terephthalate resin (A), and more than 50 parts by mass and not more than 80 parts by mass of a polystyrene resin or a rubber-reinforced polystyrene resin (B) with respect to a total of 100 parts by mass of (A) and (B), wherein the polyalkylene terephthalate resin (A) has an inherent viscosity (IV<sub>A</sub>) of 0.3-0.8 dl/g, and the polystyrene resin or the rubber-reinforced polystyrene resin (B) has a melt viscosity (Î·<sub>B</sub>) of 80 PaÂ·sec or more at 250Â°C and 912 sec<sup>-1</sup>.
Patent MX-2021007168-A (MX)
Title: Hybrid foam formulations.
Inventor: HARRIS WILLIAM J
IPC: C08G18/40
Filed: 2019-12-10
Abstract: Embodiments of the present disclosure are directed towards hybrid foam formulations that include: an isocyanate-reactive composition, and a high-functionality crosslinker; an azo type radical initiator; and an isocyanate.
Patent MX-2021011811-A (MX)
Title: Estrogen receptor degrading protacs.
Inventor: YANG BIN
IPC: C07D471/04
Filed: 2020-03-27
Abstract: The specification generally relates to compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, where R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>6</sup>, R<sup>7</sup>, R<sup>8</sup>, Linker, A, G, D and E have any of the meanings defined herein. This specification also relates to the use of such compounds and pharmaceutically acceptable salts thereof in methods of treatment of the human or animal body, for example in prevention or treatment of cancer. This specification also relates to processes and intermediate compounds involved in the preparation of such compounds and to pharmaceutical compositions containing them.
Patent MX-2021013425-A (MX)
Title: A process for the manufacture of (2s,3s,4s,5r,6s)-3,4,5-trihydrox y-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydr obenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-carboxylic acid.
Inventor: THERKELSEN FRANS DENNIS
IPC: A61P25/00
Filed: 2020-05-19
Abstract: The present invention relates to a process for manufacturing (2S,3S,4S,5R,6S)-3,4,5- trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10 a- octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carbox ylic acid with the formula (Id) below and salts thereof. The compound of formula (Id) is a prodrug of a catecholamine for use in treatment of neurodegenerative diseases and disorders such as Parkinson's Disease. The invention also relates to new intermediates of said process.
Patent MX-2021014540-A (MX)
Title: Leuprolide acetate compositions and methods of using the same to treat breast cancer.
Inventor: MIDDLETON JOHN
IPC: A61K9/00
Filed: 2020-05-26
Abstract: Compositions and methods for suppressing ovarian function in subjects with hormone receptor-positive breast cancer.
Patent MX-2022000440-A (MX)
Title: Isocyanate-free laminating adhesive.
Inventor: ZUPANCIC JOSEPH J
IPC: C08G63/91
Filed: 2020-06-10
Abstract: An epoxy terminated polyester; an adhesive formulation including the epoxy terminated polyester and a curative composition; a laminating adhesive prepared from the above adhesive formulation; a process of making a laminate; a laminate made by the above process; and a flexible package prepared from the above laminate.
Patent MX-2022001562-A (MX)
Title: Solid forms of an hpk1 inhibitor.
Inventor: JIA ZHONGJIANG
IPC: A61K31/506
Filed: 2020-08-05
Abstract: The present invention relates to salt forms of the hematopoietic progenitor kinase 1 (HPK1) inhibitors N-(2-((2S,4S)-4-Amino-2-(hydroxymethyl)pyrrolidin-1-yl)-5-fluor ophenyl)-2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxamide and N-(2-((2S,4S)-4-Amino-2-(hydroxymethyl)pyrrolidin-1-yl)-4-(4-cy anopyridin-3-yl)phenyl)-2-(2-fluoro-6-methoxyphenyl)pyrimidine-4 -carboxamide, including methods of preparation thereof, where the compounds are useful in the treatment of HPK1 mediated diseases such as cancer.
Patent MX-2022003505-A (MX)
Title: Acoustic stringed instrument body with partial taper soundboard recurve.
Inventor: GREENE FREDERICK E
IPC: G10D1/08
Filed: 2020-09-21
Abstract: A soundboard for a musical instrument having a body, a rear plate, and a lateral plate, with the soundboard, the rear plate, and the lateral plate defining a sound chamber for the musical instrument. The soundboard extends along a longitudinal axis and has a thickness. The soundboard also has a partial taper recurve asymmetrically disposed around the longitudinal axis. The recurve includes a first recurve section that forms a downward ramp which starts flush with the thickness of the soundboard, a second recurve section that defines the full depth of the partial taper recurve, and a third recurve section that forms an upward ramp which ends flush with the thickness of the soundboard. Also disclosed is a musical instrument comprising the soundboard. The musical instrument may be a guitar.
Patent MX-2022007392-A (MX)
Title: PHARMACEUTICAL COMPOSITION OF CYCLOOXYGENASE â 2 INHIBITORS.
Inventor: PATEL DINESH SHANTILAL
IPC: A61K31/415
Filed: 2020-12-11
Abstract: Present invention relates to aqueous compositions comprising cyclooxygenase-2 (COX-2) inhibitors, preferably Etoricoxib or Celecoxib or Valdecoxib or Paracoxib or salts thereof at least two solubilizers at 4.2% w/v to 19% w/v, preferably between 4.2% w/v to 18% w/v having viscosity in range of 1.0 cps to 3 cps, wherein the Etoricoxib and Celecoxib or salts thereof are present in amount ranging from 0.14 mg to 4 mg. The composition is suitable for the parenteral route of administration primarily for ready to dilute and ready to infuse which alternatively can be administered as intramuscular, intraarterial, intraocular, intraventricular, intravenous routes; also for subcutaneous, cutaneous delivery. The invention further provides a method for preparing the said composition.
Patent MX-2022008204-A (MX)
Title: Process for recovering adiponitrile.
Inventor: DUBE SANJAY
IPC: C07C253/34
Filed: 2020-12-30
Abstract: A process for producing an intermediate adiponitrile stream, the process comprising separating an adiponitrile process stream comprising less than 50 wt% adiponitrile, and optionally TCH, to form the intermediate adiponitrile stream comprising at least 5 wt% adiponitrile and a heavies stream comprising high-boiling components and optionally solid impurities; and optionally utilizing at least a portion of the intermediate adiponitrile stream outside of the process.
Patent MX-2022008912-A (MX)
Title: Method and apparatus for inspecting marine risers.
Inventor: HERNANDEZ FERNANDO CASTRO
IPC: G01N29/04
Filed: 2021-01-20
Abstract: A method and device for inspecting marine risers is described. The marine riser is deployed from a floating unit and connected to a lower marine riser package (LMRP) and a blow-out prevention (BOP) stack, and the method comprises: performing a first riser inspection with an inspection tool where the marine riser is in an unconnected well configuration, wherein the inspection tool includes an ultrasonic transducer device, and the first riser inspection comprises: conveying the inspection tool in an internal diameter of the marine riser, detecting information on the marine riser with the inspection tool while conveying the inspection tool through the marine riser, and collecting data with the inspection tool corresponding to the information detected by the inspection tool.
Patent MX-2022009146-A (MX)
Title: Quantitative control of activity of engineered cells expressing universal immune receptors.
Inventor: POWELL JR DANIEL J
IPC: A61K35/12
Filed: 2021-01-23
Abstract: The invention provides methods for stimulating a universal immune receptor-mediated response in a mammal using cells engineered to express a universal immune receptor that comprises an adaptor molecule, such as a SpyCatcher or a SpyTag moiety, a transmembrane domain, and an intracellular domain for T cell activation.
Patent MX-2022010380-A (MX)
Title: Method for monitoring the state of the powertrain or tower of a wind turbine, and wind turbine.
Inventor: RIEGER FLORIAN
IPC: F03D17/00
Filed: 2021-02-15
Abstract: Embodiments according to the invention describe a method for monitoring the state of the powertrain or tower of a wind turbine (10), said method having the steps of: detecting data of a state monitoring system which is provided for a structure of the wind turbine (10), said structure being mechanically coupled to the powertrain or tower; processing the detected data of the state monitoring system which is provided for the structure of the wind turbine (10), said structure being mechanically coupled to the powertrain or tower; and determining the state of the powertrain or tower from the processed data of the state monitoring system which is provided for the structure of the wind turbine (10), said structure being mechanically coupled to the powertrain or tower.
Patent MX-2022012501-A (MX)
Title: Carriers for efficient nucleic acid delivery.
Inventor: HUANG JIN
IPC: A61K31/7088
Filed: 2021-04-02
Abstract: Nanoparticle compositions for delivery of nucleic acids to subjects including carriers comprising polyester (PE) dendrimers or dendrons, and therapeutic or immunogenic nucleic acid agents enclosed within the PE are described. Methods for treating or preventing diseases or conditions in a subject by administering the nanoparticle compositions that provide immune responses and synergistic therapeutic or preventive effects are provided.
Patent MX-2022012826-A (MX)
Title: Method and system for attaching articles to a carrier.
Inventor: FORD COLIN P
IPC: B65D71/42
Filed: 2021-04-26
Abstract: A method of at least partially forming packages. The method comprises moving a blank and a plurality of articles in a downstream direction through a clipping station. The blank can comprise at least a first attachment panel, a second attachment panel, and a keel portion extending from the first attachment panel to the second attachment panel. The method further can comprise forming a clipped assembly by clipping the first attachment panel and the second attachment panel of the blank to respective articles of the plurality of articles during the moving the blank and the plurality of articles through the clipping station and forming a keel by moving articles of the plurality of articles toward one another and folding the keel portion of the blank between the articles as the clipped assembly is moved in the downstream direction.
Patent MX-2022014634-A (MX)
Title: Methods for lymphatic delivery of active agents.
Inventor: ROSS RUSSELL FREDERICK
IPC: A61M37/00
Filed: 2018-01-08
Abstract: The present invention concerns delivery of agents through the skin. Methods for delivering agents such as bioactive agents are contemplated by the present invention. Specifically, methods for 10 delivering an agent to the one or more areas of the epidermis and, thereby, to the lymphatic system are described.
Patent MX-NL05000027-A (MX)
Title: Device for washing vehicles and other surfaces.
Inventor: FUENTE RAUL GERARDO SANCHEZ DE
IPC: B60S3/00
Filed: 2005-03-18
Abstract: The present invention refers to a device for washing vehicles and other surfaces, which comprises a sponge having grooves, a wire located about the sponge that is twisted in order to produce a circular movement therewith, an attaching insert comprising apertures through which fastening tips are inserted, said tips being previously heated so that the attaching insert and the sponge are firmly attached together; the invention also includes a handle, and a hanging insert useful for hanging the device on any hook. The inventive device allows vehicles and other surfaces to be washed by accurately and safely operating it without wetting or damaging the user's hands.
Patent MX-PA00007202-A (MX)
Title: Household mixer-blender.
Inventor: MORIN GILLES GERARD ALBERT VICTOR
IPC: A47J43/046
Filed: 1999-01-22
Abstract: The invention concerns a household mixer-blender comprising a housing (1) with a reception seat (3) and containing an electric motor unit (4) whereof the output shaft (5) projects into the seat (3), a removable bowl (7) comprising a base (9) with a side wall (10) and urged to interlock in operating conditions on said seat and whereof the central part (12) carries a rotating tool (13) integral with a shaft (14) passing through said electric motor unit (4) base (9), and a first safety device including at least one blocking member (17) mounted retractable. The invention is characterised in that the blocking member (17) is mounted retractable in the reception seat (3) between a first inoperative position wherein it is retracted by actuating means (22) integral with the bowl base (23) when said bowl (7) is properly fixed on the base (9), and an operative position wherein it is no longer controlled by the actuating means (22) when the bowl (7) is not on the base (9) or not properly fixed thereon.
Patent MX-PA00012177-A (MX)
Title: Hyperforin derivatives, the use thereof and formulations containing them.
Inventor: MARAZZONI PAOLO
IPC: A61K36/38
Filed: 1999-06-04
Abstract: Hyperforin derivatives of formula (I), wherein R is an acyl or a glicoside group, have advantageous pharmacological characteristics and good stability.
Patent MX-PA01000143-A (MX)
Title: METHOD AND APPARATUS FOR PERFORMING SURGERY INSIDE THE HUMAN RETINA USING FLUIDIC INTERNAL LIMITING MEMBRANE (Ilm) SEPARATION (FILMS).
Inventor: MORRIS ROBERT E
IPC: A61B17/28
Filed: 1999-06-21
Abstract: A method and apparatus for performing surgery inside the human retina (26) using fluidic internal limited membrane separation (FILMS) to remove the internal limiting retinal layer (22) from the neural retinal layer (26) at the macula, is claimed. The method comprises inserting a hollow microcannula (14) between the retinal internal limiting membrane (ILM) (22) and the neural retinal layer at or near the macula and injecting a sterile fluid (20), such as sodium hyaluronate, through the microcannula (14) and thereby raising the macular ILM retinal layer (22) away from the neural retina (26) such that it can then be removed by conventional means, while simultaneously smoothing the neural retina (26) by localized pressure. The microcannula (14) maintains a distal end (12) shaped to conform tangentially to the retinal surface (26). The sharply beveled distal tip (14) is adapted for fluid discharge, and easy insertion under the ILM retinal layer (22).
Patent MX-PA01002461-A (MX)
Title: Leptin induced genes.
Inventor: TARTAGLIA LOUIS A
IPC: A61K48/00
Filed: 1999-09-10
Abstract: Six genes whose expression is induced by leptin are disclosed (LIG46; LIG56; Tgtp, encoding a T cell-specific GTP-binding protein; LRG-47, encoding an interferon (IFN) inducible protein; RC10-II, encoding a subunit of a 20S brain proteasome; and Stra13, encoding a retinoic acid inducible protein). These six leptin-inducible genes and the proteins they encode represent targets for the development of therapeutic agents for use in modulating body weight. For example, agents that alter the expression or activity of one or more of the leptin-induced proteins can be used to modulate body weight. Such agents can be identified using cellular, in vitro, or in vivo assays which monitor the expression or activity of one or more of the six leptin-induced proteins. Potentially useful therapeutic agents can also be identified through the use of assays designed to identify agents that bind to one of the leptin-induced proteins. The leptin-induced genes of the invention and the proteins they encode may themselves be useful therapeutically and diagnostically.
Patent MX-PA01012934-A (MX)
Title: Coating material and its use for producing filler coats and stone impact protection primers.
Inventor: BREMSER WOLFGANG
IPC: C08F220/14
Filed: 2000-06-23
Abstract: The invention relates to a copolymerizate (A) which can be produced in an aqueous medium by radically polymerizing: a) at least one olefinically unsaturated monomer, and b) at least one olefinically unsaturated monomer which is different from the olefinically unsaturated monomer cited in a) and which is of general formula (I) R1R2C=CR3R4 (I), wherein the radicals R1, R2, R3 and R4, independent of one another, represent hydrogen atoms or substituted or non-substituted radicals of alkyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, aryl, alkylaryl, cycloalkylaryl, arylalkyl or arylcycloalkyl, with the provision that at least two of the variables R1, R2, R3 and R4 represent substituted or non-substituted radicals of aryl, arylalkyl or arylcycloalkyl, especially substituted or non-substituted aryl radicals. Said copolymerizate is used in a coating material which serves to produce filler coats and stone impact protection primers.
Patent MX-PA02002059-A (MX)
Title: Pesticide protective articles.
Inventor: GANG SUN
IPC: A01N43/50
Filed: 2000-08-30
Abstract: The present invention provides methods for preparing an article capable of detoxifying a pesticide, such as textiles, comprising: (a) immersing the article in an aqueous treating solution which comprises a catalyst, a wetting agent and a heterocyclic amine; and (b) treating the article with a halogenated aqueous solution, thereby rendering the article capable of detoxifying a pesticide.
Patent MX-PA02002285-A (MX)
Title: Intraocular lenses.
Inventor: ROSS MARCH W
IPC: A61F9/007
Filed: 2000-08-29
Abstract: A refractive intraocular (26) lens including an optic portion (28) having an outer peripheral edge (30) and two or more but preferably two, three or four balanced haptic elements (32). Each haptic element (32) is of like form to achieve a propeller like appearance. Each haptic element (32) is also manufactured to have an inner portion (34) and an outer tip (36) for supporting the optic portion (28) in a patient s eye. The inner portion (34) of each haptic element (32) is permanently connected to the outer peripheral edge of the optic portion. Each haptic element (32) also includes a contact plate (38) and a central portion (44) located between the contact plate (38) and the inner portion (34). Each haptic (32) is formed to have greater resistance to bending in a plane generally parallel to an eye s optical axis than in a plane (48.48) generally perpendicular to the eye s optical axis. The intraocular lens (26) is so designed to exhibit less than approximately 1.0 mm axial displacement of the optic portion along the eye s optical axis under a compression force suitable to effect a 1.0 mm in diameter compression of the intraocular lens (26).